This integrated system serves as the core facility for biopharmaceutical and biotech production, covering complete upstream biomanufacturing workflows including cell banking, seed culture expansion, medium preparation and large-scale bioreactor cultivation. It precisely controls temperature, pH, dissolved oxygen and other key parameters to achieve stable cell growth and efficient biosynthesis of target products such as monoclonal antibodies, recombinant proteins and vaccines. Featuring reliable performance, easy process scaling and full compliance with GMP standards, it realizes seamless technology transfer and high-yield, high-quality upstream production, laying a solid foundation for subsequent downstream purification.
